Concepts (373)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Progesterone | 72 | 2018 | 110 | 6.200 |
Why?
|
| Estradiol | 85 | 2020 | 257 | 5.040 |
Why?
|
| Sexual Behavior, Animal | 64 | 2018 | 87 | 5.010 |
Why?
|
| Receptors, Estrogen | 54 | 2018 | 128 | 4.210 |
Why?
|
| Progesterone | 56 | 2015 | 163 | 3.460 |
Why?
|
| Hypothalamus | 47 | 2021 | 132 | 3.050 |
Why?
|
| Sexual Maturation | 10 | 2015 | 51 | 2.610 |
Why?
|
| Brain | 35 | 2017 | 1554 | 1.830 |
Why?
|
| Neurons | 32 | 2007 | 919 | 1.830 |
Why?
|
| Preoptic Area | 32 | 2004 | 50 | 1.560 |
Why?
|
| Prosencephalon | 13 | 2003 | 37 | 1.560 |
Why?
|
| Endocrinology | 5 | 2012 | 21 | 1.550 |
Why?
|
| Ovariectomy | 42 | 2016 | 102 | 1.490 |
Why?
|
| Copulation | 13 | 2009 | 17 | 1.460 |
Why?
|
| Rats | 72 | 2019 | 1980 | 1.450 |
Why?
|
| Animals | 151 | 2021 | 20617 | 1.350 |
Why?
|
| Puberty | 3 | 2015 | 59 | 1.270 |
Why?
|
| Stress, Physiological | 6 | 2015 | 193 | 1.220 |
Why?
|
| Lipopolysaccharides | 7 | 2021 | 644 | 1.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 12 | 2003 | 52 | 1.190 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 10 | 2019 | 10 | 1.140 |
Why?
|
| Guinea Pigs | 40 | 2009 | 84 | 1.010 |
Why?
|
| Immunohistochemistry | 35 | 2017 | 890 | 0.980 |
Why?
|
| Microglia | 2 | 2020 | 242 | 0.960 |
Why?
|
| Female | 140 | 2021 | 32566 | 0.940 |
Why?
|
| Sex Characteristics | 7 | 2012 | 203 | 0.910 |
Why?
|
| Progestins | 8 | 2014 | 29 | 0.890 |
Why?
|
| Behavior, Animal | 7 | 2014 | 228 | 0.850 |
Why?
|
| Gonadal Hormones | 3 | 2013 | 5 | 0.840 |
Why?
|
| Rats, Sprague-Dawley | 28 | 2018 | 622 | 0.830 |
Why?
|
| Ovary | 7 | 2015 | 99 | 0.830 |
Why?
|
| Hypothalamus, Middle | 15 | 1996 | 20 | 0.810 |
Why?
|
| Science | 2 | 2018 | 34 | 0.800 |
Why?
|
| Dopamine | 8 | 2004 | 105 | 0.790 |
Why?
|
| Cervix Uteri | 10 | 2003 | 58 | 0.770 |
Why?
|
| Vagina | 9 | 2003 | 82 | 0.730 |
Why?
|
| Cognition | 3 | 2015 | 481 | 0.720 |
Why?
|
| Publishing | 3 | 2012 | 92 | 0.700 |
Why?
|
| Estrogen Receptor alpha | 8 | 2016 | 49 | 0.690 |
Why?
|
| Estrus | 13 | 2004 | 26 | 0.660 |
Why?
|
| Periodicals as Topic | 3 | 2012 | 174 | 0.660 |
Why?
|
| Sexual Behavior | 3 | 2012 | 194 | 0.650 |
Why?
|
| Posture | 17 | 2018 | 127 | 0.650 |
Why?
|
| Receptors, Steroid | 3 | 2012 | 26 | 0.650 |
Why?
|
| Estrogens | 6 | 2011 | 115 | 0.630 |
Why?
|
| Substance P | 6 | 1997 | 38 | 0.620 |
Why?
|
| Achievement | 1 | 2018 | 27 | 0.610 |
Why?
|
| Brain Chemistry | 6 | 2009 | 76 | 0.600 |
Why?
|
| Sex Differentiation | 4 | 2009 | 9 | 0.590 |
Why?
|
| Mesencephalon | 10 | 2004 | 28 | 0.580 |
Why?
|
| Mice | 18 | 2021 | 10819 | 0.570 |
Why?
|
| Gonadal Steroid Hormones | 6 | 2011 | 31 | 0.560 |
Why?
|
| Amygdala | 10 | 2017 | 83 | 0.530 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2021 | 88 | 0.520 |
Why?
|
| Cell Nucleus | 31 | 2004 | 623 | 0.490 |
Why?
|
| Nerve Tissue Proteins | 4 | 2001 | 424 | 0.490 |
Why?
|
| Mifepristone | 11 | 2018 | 19 | 0.470 |
Why?
|
| Stress, Psychological | 4 | 2013 | 469 | 0.460 |
Why?
|
| Immunity | 2 | 2013 | 107 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 9 | 2020 | 3389 | 0.400 |
Why?
|
| Hormones | 2 | 2012 | 60 | 0.400 |
Why?
|
| Gonadotropin-Releasing Hormone | 7 | 2014 | 87 | 0.400 |
Why?
|
| Cytosol | 23 | 1991 | 180 | 0.390 |
Why?
|
| Environment | 3 | 2012 | 122 | 0.390 |
Why?
|
| Tissue Distribution | 12 | 2004 | 293 | 0.370 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 24 | 0.370 |
Why?
|
| Lactation | 2 | 2003 | 69 | 0.370 |
Why?
|
| Receptors, Dopamine D1 | 3 | 2001 | 24 | 0.360 |
Why?
|
| Anti-Anxiety Agents | 1 | 2011 | 32 | 0.360 |
Why?
|
| Corticosterone | 5 | 2013 | 23 | 0.360 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 99 | 0.360 |
Why?
|
| Models, Genetic | 1 | 2012 | 260 | 0.360 |
Why?
|
| Immune System | 1 | 2012 | 130 | 0.360 |
Why?
|
| Pituitary-Adrenal System | 1 | 2011 | 60 | 0.350 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 225 | 0.350 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 158 | 0.350 |
Why?
|
| Genes, fos | 4 | 2000 | 18 | 0.340 |
Why?
|
| Neuroendocrinology | 1 | 2009 | 2 | 0.330 |
Why?
|
| Hypothalamic Area, Lateral | 4 | 1994 | 6 | 0.330 |
Why?
|
| Central Nervous System | 2 | 2009 | 197 | 0.330 |
Why?
|
| Estrogen Receptor beta | 5 | 2016 | 24 | 0.330 |
Why?
|
| Scientific Misconduct | 1 | 2010 | 12 | 0.330 |
Why?
|
| Norepinephrine | 7 | 1994 | 103 | 0.330 |
Why?
|
| Sex Factors | 2 | 2012 | 975 | 0.330 |
Why?
|
| Dopamine beta-Hydroxylase | 7 | 1991 | 13 | 0.320 |
Why?
|
| Rats, Inbred Strains | 19 | 1993 | 150 | 0.320 |
Why?
|
| Peer Review, Research | 1 | 2010 | 47 | 0.320 |
Why?
|
| Hormone Antagonists | 4 | 2018 | 12 | 0.310 |
Why?
|
| Phosphoproteins | 2 | 2001 | 219 | 0.310 |
Why?
|
| Transportation | 1 | 2009 | 33 | 0.300 |
Why?
|
| Transcriptome | 1 | 2012 | 385 | 0.300 |
Why?
|
| Estrogen Antagonists | 6 | 2019 | 16 | 0.290 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2004 | 35 | 0.290 |
Why?
|
| Anxiety | 1 | 2011 | 423 | 0.290 |
Why?
|
| Food Deprivation | 4 | 2009 | 12 | 0.270 |
Why?
|
| Pituitary Gland | 8 | 1990 | 51 | 0.270 |
Why?
|
| Biomedical Research | 1 | 2009 | 264 | 0.270 |
Why?
|
| Physical Stimulation | 6 | 2009 | 30 | 0.260 |
Why?
|
| Down-Regulation | 3 | 2009 | 318 | 0.250 |
Why?
|
| Immunity, Innate | 1 | 2012 | 794 | 0.250 |
Why?
|
| Cyclic AMP | 3 | 2019 | 143 | 0.250 |
Why?
|
| Pituitary Gland, Anterior | 4 | 1987 | 30 | 0.250 |
Why?
|
| Depression | 1 | 2012 | 884 | 0.240 |
Why?
|
| Male | 31 | 2021 | 29552 | 0.240 |
Why?
|
| Photoperiod | 2 | 2011 | 40 | 0.240 |
Why?
|
| Zearalenone | 1 | 2004 | 1 | 0.240 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 35 | 0.230 |
Why?
|
| Cell Count | 5 | 2011 | 130 | 0.230 |
Why?
|
| Stilbamidines | 2 | 1994 | 2 | 0.220 |
Why?
|
| Reproduction | 2 | 1994 | 92 | 0.210 |
Why?
|
| Luteinizing Hormone | 7 | 2021 | 99 | 0.210 |
Why?
|
| Proestrus | 1 | 2003 | 3 | 0.210 |
Why?
|
| Pregnancy, Animal | 1 | 2003 | 9 | 0.210 |
Why?
|
| Estrenes | 4 | 1987 | 9 | 0.210 |
Why?
|
| Estrous Cycle | 4 | 2016 | 12 | 0.200 |
Why?
|
| Odorants | 1 | 2002 | 17 | 0.200 |
Why?
|
| Humans | 18 | 2018 | 62868 | 0.190 |
Why?
|
| Age Factors | 3 | 2012 | 1556 | 0.190 |
Why?
|
| Cytoplasm | 8 | 1997 | 277 | 0.190 |
Why?
|
| Mesocricetus | 9 | 1999 | 94 | 0.190 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 45 | 0.190 |
Why?
|
| Mechanoreceptors | 1 | 2001 | 13 | 0.180 |
Why?
|
| Cricetinae | 10 | 1999 | 368 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2015 | 863 | 0.180 |
Why?
|
| Castration | 18 | 1984 | 41 | 0.180 |
Why?
|
| Illness Behavior | 2 | 2011 | 4 | 0.180 |
Why?
|
| Receptors, Kisspeptin-1 | 1 | 2021 | 10 | 0.180 |
Why?
|
| Kisspeptins | 1 | 2021 | 23 | 0.180 |
Why?
|
| Time Factors | 10 | 2015 | 3749 | 0.170 |
Why?
|
| Maternal Behavior | 1 | 2000 | 32 | 0.170 |
Why?
|
| Lordosis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Promegestone | 10 | 1996 | 11 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2003 | 233 | 0.160 |
Why?
|
| Antibodies | 3 | 2000 | 182 | 0.160 |
Why?
|
| Vocational Guidance | 1 | 2018 | 19 | 0.150 |
Why?
|
| Colchicine | 3 | 1993 | 28 | 0.150 |
Why?
|
| Awards and Prizes | 1 | 2018 | 34 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 187 | 0.150 |
Why?
|
| Receptors, LHRH | 1 | 2018 | 8 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1987 | 4 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2018 | 170 | 0.140 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1997 | 8 | 0.140 |
Why?
|
| Dopamine Agonists | 1 | 1997 | 22 | 0.140 |
Why?
|
| Gene Expression | 3 | 1998 | 838 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 127 | 0.130 |
Why?
|
| Neurons, Efferent | 1 | 1996 | 3 | 0.130 |
Why?
|
| Neurotransmitter Agents | 2 | 2012 | 42 | 0.130 |
Why?
|
| Eating | 2 | 1992 | 138 | 0.120 |
Why?
|
| Pyrrolidines | 3 | 1982 | 11 | 0.120 |
Why?
|
| Immune System Phenomena | 1 | 2015 | 3 | 0.120 |
Why?
|
| Uterus | 2 | 2004 | 42 | 0.120 |
Why?
|
| Energy Metabolism | 3 | 1994 | 378 | 0.120 |
Why?
|
| Hippocampus | 1 | 2017 | 267 | 0.120 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 81 | 0.120 |
Why?
|
| Clonidine | 4 | 1989 | 25 | 0.120 |
Why?
|
| Mice, Inbred Strains | 3 | 2012 | 189 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2015 | 72 | 0.110 |
Why?
|
| Epitopes | 2 | 1993 | 296 | 0.110 |
Why?
|
| Body Weight | 4 | 2009 | 377 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2011 | 608 | 0.110 |
Why?
|
| Dinoprostone | 1 | 2014 | 43 | 0.110 |
Why?
|
| Research Design | 2 | 2010 | 573 | 0.110 |
Why?
|
| Touch | 1 | 1994 | 27 | 0.110 |
Why?
|
| Nervous System | 1 | 1994 | 69 | 0.110 |
Why?
|
| Benzazepines | 3 | 2003 | 21 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2003 | 3027 | 0.100 |
Why?
|
| Animals, Outbred Strains | 1 | 2012 | 7 | 0.100 |
Why?
|
| Prazosin | 3 | 1987 | 9 | 0.100 |
Why?
|
| Tamoxifen | 4 | 2018 | 41 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2000 | 1614 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 2012 | 27 | 0.100 |
Why?
|
| Dendrites | 1 | 1992 | 56 | 0.100 |
Why?
|
| Social Behavior | 1 | 2012 | 91 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 194 | 0.090 |
Why?
|
| Radioimmunoassay | 2 | 2009 | 63 | 0.090 |
Why?
|
| Injections, Intraventricular | 4 | 2014 | 21 | 0.090 |
Why?
|
| Phenylthiazolylthiourea | 3 | 1986 | 3 | 0.090 |
Why?
|
| Axons | 1 | 1992 | 123 | 0.090 |
Why?
|
| Adrenalectomy | 2 | 2009 | 25 | 0.090 |
Why?
|
| Facility Design and Construction | 1 | 2011 | 11 | 0.090 |
Why?
|
| Renin | 1 | 2011 | 10 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2011 | 24 | 0.090 |
Why?
|
| Maze Learning | 1 | 2011 | 53 | 0.090 |
Why?
|
| Aldosterone | 1 | 2011 | 18 | 0.090 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 3 | 1999 | 18 | 0.090 |
Why?
|
| Proteins | 1 | 1997 | 751 | 0.090 |
Why?
|
| Vibration | 1 | 2011 | 26 | 0.090 |
Why?
|
| Time | 1 | 2011 | 30 | 0.090 |
Why?
|
| Yohimbine | 2 | 1987 | 9 | 0.090 |
Why?
|
| Neural Pathways | 3 | 1999 | 98 | 0.090 |
Why?
|
| Feeding Behavior | 3 | 1978 | 259 | 0.090 |
Why?
|
| Noise | 1 | 2011 | 33 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 4 | 1997 | 108 | 0.090 |
Why?
|
| beta-Endorphin | 1 | 1990 | 8 | 0.090 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 1987 | 16 | 0.090 |
Why?
|
| Enkephalins | 1 | 1990 | 20 | 0.090 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 2 | 2001 | 9 | 0.090 |
Why?
|
| Peptides | 1 | 2014 | 576 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2012 | 366 | 0.080 |
Why?
|
| Epigenesis, Genetic | 2 | 2012 | 384 | 0.080 |
Why?
|
| Plagiarism | 1 | 2010 | 4 | 0.080 |
Why?
|
| Private Sector | 1 | 2010 | 12 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2010 | 22 | 0.080 |
Why?
|
| Periodicity | 1 | 1990 | 49 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2010 | 78 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2008 | 1534 | 0.080 |
Why?
|
| Testosterone Propionate | 1 | 2009 | 1 | 0.080 |
Why?
|
| Phytohemagglutinins | 3 | 1999 | 15 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2009 | 75 | 0.080 |
Why?
|
| Norpregnadienes | 2 | 1979 | 2 | 0.080 |
Why?
|
| Light | 1 | 1990 | 201 | 0.080 |
Why?
|
| Random Allocation | 1 | 2009 | 198 | 0.080 |
Why?
|
| Microscopy, Electron | 3 | 1997 | 250 | 0.080 |
Why?
|
| Vasopressins | 1 | 2008 | 15 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 2008 | 8 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2008 | 30 | 0.070 |
Why?
|
| Orchiectomy | 4 | 1994 | 31 | 0.070 |
Why?
|
| Reproductive Behavior | 1 | 2008 | 4 | 0.070 |
Why?
|
| Perfusion | 3 | 1993 | 73 | 0.070 |
Why?
|
| Motor Skills Disorders | 1 | 2007 | 5 | 0.070 |
Why?
|
| Kinetics | 5 | 1994 | 764 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 47 | 0.070 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2007 | 27 | 0.070 |
Why?
|
| Obesity | 3 | 2009 | 1230 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2001 | 937 | 0.070 |
Why?
|
| Apomorphine | 1 | 1987 | 3 | 0.070 |
Why?
|
| In Situ Hybridization | 2 | 2008 | 218 | 0.070 |
Why?
|
| Pregnancy | 7 | 2003 | 2326 | 0.070 |
Why?
|
| Transcription Factors | 3 | 2006 | 1508 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2008 | 140 | 0.070 |
Why?
|
| Drug Implants | 3 | 2008 | 15 | 0.070 |
Why?
|
| Aging | 2 | 1991 | 743 | 0.070 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 16 | 0.070 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 1999 | 143 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 59 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 1985 | 150 | 0.060 |
Why?
|
| Phenylthiourea | 1 | 1986 | 2 | 0.060 |
Why?
|
| Cerebral Cortex | 6 | 1988 | 258 | 0.060 |
Why?
|
| Leptin | 2 | 2014 | 85 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2015 | 142 | 0.060 |
Why?
|
| Binding, Competitive | 5 | 1996 | 100 | 0.060 |
Why?
|
| DDT | 1 | 1984 | 3 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 1994 | 198 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 1987 | 317 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2008 | 2105 | 0.060 |
Why?
|
| Microinjections | 2 | 2019 | 68 | 0.060 |
Why?
|
| Organ Size | 1 | 2004 | 171 | 0.060 |
Why?
|
| Cerebral Ventricles | 2 | 1994 | 29 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 5 | 2002 | 866 | 0.050 |
Why?
|
| Testosterone | 4 | 2008 | 119 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 639 | 0.050 |
Why?
|
| Organ Specificity | 2 | 1994 | 193 | 0.050 |
Why?
|
| Anisomycin | 1 | 1982 | 6 | 0.050 |
Why?
|
| Ejaculation | 1 | 2002 | 8 | 0.050 |
Why?
|
| Adolescent | 1 | 2013 | 6195 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 1997 | 667 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1066 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 1994 | 198 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 1982 | 70 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2001 | 15 | 0.050 |
Why?
|
| Drug Synergism | 2 | 1995 | 142 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2001 | 16 | 0.050 |
Why?
|
| Sensory Deprivation | 1 | 2001 | 4 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2021 | 84 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5596 | 0.050 |
Why?
|
| Nitromifene | 2 | 1979 | 2 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2001 | 610 | 0.040 |
Why?
|
| Gonanes | 2 | 1997 | 2 | 0.040 |
Why?
|
| Infusions, Intraventricular | 1 | 2019 | 12 | 0.040 |
Why?
|
| Carbazoles | 1 | 2019 | 13 | 0.040 |
Why?
|
| Thionucleotides | 1 | 2019 | 38 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 411 | 0.040 |
Why?
|
| Flavonoids | 1 | 2019 | 74 | 0.040 |
Why?
|
| Animals, Newborn | 3 | 1989 | 237 | 0.040 |
Why?
|
| Astrocytes | 1 | 2000 | 119 | 0.040 |
Why?
|
| Iontophoresis | 1 | 1999 | 3 | 0.040 |
Why?
|
| Behavior | 2 | 2012 | 36 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2019 | 135 | 0.040 |
Why?
|
| Progesterone Congeners | 1 | 1978 | 6 | 0.040 |
Why?
|
| Nafoxidine | 1 | 1978 | 1 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 1997 | 17 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1977 | 6 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2018 | 133 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1997 | 22 | 0.030 |
Why?
|
| Mice, Obese | 1 | 1997 | 80 | 0.030 |
Why?
|
| Hyperphagia | 1 | 1976 | 18 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1987 | 89 | 0.030 |
Why?
|
| Fertility | 1 | 1997 | 80 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 373 | 0.030 |
Why?
|
| Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide | 2 | 1986 | 2 | 0.030 |
Why?
|
| Ditiocarb | 2 | 1986 | 3 | 0.030 |
Why?
|
| United States | 1 | 2009 | 7744 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 1184 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 1995 | 381 | 0.030 |
Why?
|
| Vagotomy | 1 | 1994 | 6 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 1994 | 20 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 1994 | 31 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1994 | 18 | 0.030 |
Why?
|
| Oxytocin | 1 | 1994 | 45 | 0.030 |
Why?
|
| Injections | 1 | 1993 | 81 | 0.030 |
Why?
|
| Shrews | 1 | 1992 | 2 | 0.030 |
Why?
|
| Insulin | 2 | 1992 | 687 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1992 | 32 | 0.030 |
Why?
|
| Brain Mapping | 1 | 1994 | 232 | 0.020 |
Why?
|
| Species Specificity | 3 | 1997 | 336 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 1986 | 47 | 0.020 |
Why?
|
| Thalamus | 1 | 1993 | 66 | 0.020 |
Why?
|
| Varicose Veins | 1 | 1991 | 7 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1992 | 487 | 0.020 |
Why?
|
| Binding Sites | 1 | 1993 | 902 | 0.020 |
Why?
|
| Cholesterol | 1 | 1991 | 259 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 1989 | 11 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 179 | 0.020 |
Why?
|
| Weaning | 1 | 1989 | 8 | 0.020 |
Why?
|
| Receptors, Adrenergic | 1 | 1989 | 8 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 453 | 0.020 |
Why?
|
| Silver Staining | 1 | 2008 | 5 | 0.020 |
Why?
|
| Steroids | 1 | 2008 | 54 | 0.020 |
Why?
|
| Idazoxan | 1 | 1987 | 1 | 0.020 |
Why?
|
| Dioxanes | 1 | 1987 | 5 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1987 | 20 | 0.020 |
Why?
|
| Drug Antagonism | 2 | 1977 | 9 | 0.020 |
Why?
|
| Reference Values | 1 | 1988 | 335 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 1977 | 70 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1987 | 18 | 0.020 |
Why?
|
| Catecholamines | 1 | 1987 | 31 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2006 | 16 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 1997 | 302 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2007 | 204 | 0.020 |
Why?
|
| Methyltyrosines | 1 | 1986 | 2 | 0.020 |
Why?
|
| alpha-Methyltyrosine | 1 | 1986 | 2 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 573 | 0.020 |
Why?
|
| Hysterectomy | 1 | 1986 | 67 | 0.020 |
Why?
|
| Pharmacokinetics | 1 | 2004 | 6 | 0.010 |
Why?
|
| Sex Chromosomes | 1 | 2004 | 8 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 344 | 0.010 |
Why?
|
| Methysergide | 1 | 1984 | 1 | 0.010 |
Why?
|
| Tachyphylaxis | 1 | 1984 | 3 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 81 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1984 | 127 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1997 | 1273 | 0.010 |
Why?
|
| Sodium Glutamate | 1 | 1982 | 1 | 0.010 |
Why?
|
| Glutamates | 1 | 1982 | 13 | 0.010 |
Why?
|
| Base Sequence | 2 | 1994 | 1335 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 1997 | 0.010 |
Why?
|
| Columbidae | 1 | 1980 | 12 | 0.010 |
Why?
|
| Substantia Innominata | 1 | 2000 | 1 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 2000 | 25 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1979 | 4 | 0.010 |
Why?
|
| Norgestrel | 1 | 1979 | 1 | 0.010 |
Why?
|
| 20-alpha-Dihydroprogesterone | 1 | 1979 | 7 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 456 | 0.010 |
Why?
|
| Dihydrotestosterone | 2 | 1994 | 19 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1997 | 8 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1977 | 6 | 0.010 |
Why?
|
| Gonads | 1 | 1997 | 15 | 0.010 |
Why?
|
| Aurothioglucose | 1 | 1976 | 2 | 0.010 |
Why?
|
| Homozygote | 1 | 1996 | 124 | 0.010 |
Why?
|
| Serotonin | 1 | 1996 | 60 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1995 | 10 | 0.010 |
Why?
|
| Efferent Pathways | 1 | 1995 | 13 | 0.010 |
Why?
|
| Genotype | 1 | 1997 | 666 | 0.010 |
Why?
|
| Dopamine Agents | 1 | 1994 | 11 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1994 | 33 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1991 | 53 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 1194 | 0.010 |
Why?
|
| DNA | 1 | 1994 | 840 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 332 | 0.000 |
Why?
|
| Mutation | 1 | 1996 | 2598 | 0.000 |
Why?
|
| Hypothalamus, Anterior | 1 | 1982 | 4 | 0.000 |
Why?
|
| Prolactin | 1 | 1982 | 40 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1981 | 3 | 0.000 |
Why?
|